{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:07:42Z","timestamp":1791324462497,"version":"4.3.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Recent studies have shown that disruption of circadian rhythms is one of the tumor promoting factors which contribute to mammalian cancer development and progression, but very little is known about the molecular changes of circadian genes in colorectal carcinoma (CRC). Thus, in this study, changes in the expression of human Period2 (hPer2), one of the key circadian clock regulators, in CRC and its correlation with prognosis were investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Immunohistochemical (IHC) staining and real-time PCR for hPer2 were performed for 38 CRC cases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>IHC analysis detected positive staining for hPer2 in 81.6% (31\/38) of CRC tissues and 97.4% (37\/38) of surrounding non-cancerous tissues (P &lt; 0.05). Most colorectal cells in non-cancerous tissues were homogeneously stained. In contrast, in the paired cancerous tissues, a heterogeneous pattern was found with a significant portion of cancer cells displaying negative or weak hPer2 staining. In over 60% cases (24\/38), the staining for hPer2 was much stronger in non-cancerous cells than in the paired cancerous cells. Well-differentiated cancer cells are more likely to maintain hPer2 expression than poorly-differentiated ones. Furthermore, associations of decreased hPer2 levels with patients' age, histological grade, TNM stage and expression of nucleus proliferation related antigen: Ki67 were also detected (P &lt; 0.05). Expression of hPer2 did not correlate with that of either p53 or C-erB-2. Similar to hPer2 protein expression, quantitative RT-PCR for hPer2 also showed decreased mRNA expression in CRC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>These results suggest a role for hPer2 in normal colorectal cell function and the potential deregulation of hPer2 expression in the development, invasion, and metastasis of CRC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-7819-9-166","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T19:23:31Z","timestamp":1323804211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Expression of circadian clock gene human Period2 (hPer2) in human colorectal carcinoma"],"prefix":"10.1186","volume":"9","author":[{"given":"Yaping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luchun","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,13]]},"reference":[{"key":"911_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1101\/sqb.2007.72.004","volume":"72","author":"S Gery","year":"2007","unstructured":"Gery S, Koeffler HP: The Role of Circadian Regulation in Cancer. [J] Cold Spring Harb Symp Quant Biol. 2007, 72: 459-464. 10.1101\/sqb.2007.72.004.","journal-title":"[J] Cold Spring Harb Symp Quant Biol"},{"issue":"4","key":"911_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/0748730407303387","volume":"22","author":"CG Misty","year":"2007","unstructured":"Misty CG, Cheng CL, Lee CC: Tumor Suppression and Circadian Function. [J] Journal of Biological Rhythms. 2007, 22 (4): 291-298. 10.1177\/0748730407303387.","journal-title":"[J] Journal of Biological Rhythms"},{"issue":"2","key":"911_CR3","doi-asserted-by":"publisher","first-page":"R271","DOI":"10.1093\/hmg\/ddl207","volume":"15","author":"CH Ko","year":"2006","unstructured":"Ko CH, Takahashi JS: Molecular components of the mammalian circadian clock. [J] Hum Mol Genet. 2006, 15 (2): R271-277. 10.1093\/hmg\/ddl207.","journal-title":"[J] Hum Mol Genet"},{"issue":"4","key":"911_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-2443.2010.01384.x","volume":"15","author":"M Koyomi","year":"2010","unstructured":"Koyomi M, Miyuki W, Yasuhiro H, Ishida N: Tumor growth suppression in vivo by overexpression of the circadian component, PER2. [J] Genes to Cells. 2010, 15 (4): 351-358. 10.1111\/j.1365-2443.2010.01384.x.","journal-title":"[J] Genes to Cells"},{"issue":"4","key":"911_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/1534735409352083","volume":"8","author":"XM Yang","year":"2009","unstructured":"Yang XM, Wood PA, Ansell C, Hrushesky WJM: Circadian time-dependent tumor suppressor function of Period genes. [J] Integrative Cancer Therapies. 2009, 8 (4): 309-316. 10.1177\/1534735409352083.","journal-title":"[J] Integrative Cancer Therapies"},{"issue":"7","key":"911_CR6","first-page":"1241","volume":"26","author":"ST Chen","year":"2005","unstructured":"Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG: Deregulated expression of the PER1, PER2 and PER3 gene in breast cancer. [J] Oxford University Press. 2005, 26 (7): 1241-1246.","journal-title":"[J] Oxford University Press"},{"issue":"8","key":"911_CR7","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1182\/blood-2005-01-0358","volume":"106","author":"S Gery","year":"2005","unstructured":"Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP: Transcription profiling of C\/EBP targets identifies Per2 as a gene implicated in myeloid leukemia. [J] Blood. 2005, 106 (8): 2827-2836. 10.1182\/blood-2005-01-0358.","journal-title":"[J] Blood"},{"issue":"22","key":"911_CR8","first-page":"7545","volume":"63","author":"C Laurence","year":"2003","unstructured":"Laurence C, Tomoko K, Vincent L: The days and Nights of cancer cells. [J] Cancer Research. 2003, 63 (22): 7545-7552.","journal-title":"[J] Cancer Research"},{"issue":"9","key":"911_CR9","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/jnci\/94.9.690","volume":"94","author":"E Filipski","year":"2002","unstructured":"Filipski E: Host circadian clock as a control point in tumour progression. [J] Natl Cancer Inst. 2002, 94 (9): 690-697.","journal-title":"[J] Natl Cancer Inst"},{"issue":"1","key":"911_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0092-8674(02)00961-3","volume":"111","author":"L Fu","year":"2002","unstructured":"Fu L, Pelicano H, Liu JS, Huang P, Lee CC: The circadian gene period2 plays an important role in tumor suppression and DNA damage response in vivo. [J] Cell. 2002, 111 (1): 41-50. 10.1016\/S0092-8674(02)00961-3.","journal-title":"[J] Cell"},{"issue":"57","key":"911_CR11","doi-asserted-by":"publisher","first-page":"7916","DOI":"10.1038\/sj.onc.1210585","volume":"26","author":"S Gery","year":"2007","unstructured":"Gery S, Virk RK, Chumakov K, Yu A, Koeffler HP: The clock gene Per2 links the circadian system to the estrogen receptor. [J] Oncogene. 2007, 26 (57): 7916-7920. 10.1038\/sj.onc.1210585.","journal-title":"[J] Oncogene"},{"issue":"9","key":"911_CR12","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/sj.cgt.7701061","volume":"14","author":"H Hua","year":"2007","unstructured":"Hua H, Wang Y, Wan C, Liu Y, Zhu B, Wang Z, Ding JM: Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL\/6 mice. [J] Cancer Gene Ther. 2007, 14 (9): 815-818. 10.1038\/sj.cgt.7701061.","journal-title":"[J] Cancer Gene Ther"},{"issue":"7","key":"911_CR13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1349-7006.2006.00225.x","volume":"97","author":"H Hua","year":"2006","unstructured":"Hua H, Wang Y, Wan C, Liu Y, Zhu B, Yang C, Wang X, Wang Z, Cornelissen-Guillaume G, Halberg F: Circadian gene mPer2 overexpression induces cancer cell apoptosis. [J] Cancer Sci. 2006, 97 (7): 589-596. 10.1111\/j.1349-7006.2006.00225.x.","journal-title":"[J] Cancer Sci"},{"issue":"5","key":"911_CR14","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/S0002-9440(10)64135-1","volume":"158","author":"GA Bjarnason","year":"2001","unstructured":"Bjarnason GA, Jordan RC, Wood PA, Li Q, Lincoln DW, Sothern RB, Hrushesky WJ, Ben-David Y: Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases. [J] Am J Pathol. 2001, 158 (5): 1793-1801. 10.1016\/S0002-9440(10)64135-1.","journal-title":"[J] Am J Pathol"},{"issue":"12","key":"911_CR15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/jnci\/92.12.987","volume":"92","author":"MS Orr","year":"2000","unstructured":"Orr MS, O'Connor PM, Kohn KW: Effects of c-erbB2 overexpression on the drug sensitivities of normal human mammary epithelial cells. [J] Natl Cancer Inst. 2000, 92 (12): 987-994. 10.1093\/jnci\/92.12.987.","journal-title":"[J] Natl Cancer Inst"},{"issue":"5","key":"911_CR16","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S0016-5085(98)70312-9","volume":"114","author":"WJ Karnes","year":"1998","unstructured":"Karnes WJ, Weller SG, Adjei PN, Kottke TJ, Glenn KS, Gores GJ, Kaufmann SH: Inhibition of epidermal growth factor receptor kinase induces proteasedependent apoptosis in human colon cancer cells. [J] Gastroenterology. 1998, 114 (5): 930-939. 10.1016\/S0016-5085(98)70312-9.","journal-title":"[J] Gastroenterology"},{"issue":"6810","key":"911_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35042675","volume":"408","author":"B Vogelstein","year":"2000","unstructured":"Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. [J] Nature. 2000, 408 (6810): 307-310. 10.1038\/35042675.","journal-title":"[J] Nature"},{"key":"911_CR18","volume-title":"Colorectal Cancer Facts and Figures","author":"S Rebecca","year":"2011","unstructured":"Rebecca S, Ahmedin J: Colorectal Cancer Facts and Figures. 2011, American Cancer Society (ACS), Atlanta, Georgia, http:\/\/www.cancer.org\/Research\/CancerFactsFigures\/ColorectalCancerFactsFigures"},{"issue":"2","key":"911_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/BF02855647","volume":"2","author":"S Zheng","year":"2003","unstructured":"Zheng S, Cai SR: Colorectal cancer epidemiology and prevention study in China. [J] The Chinese-German journal of clinical oncology. 2003, 2 (2): 72-75. 10.1007\/BF02855647.","journal-title":"[J] The Chinese-German journal of clinical oncology"},{"issue":"1","key":"911_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cell.2009.08.031","volume":"139","author":"EE Zhang","year":"2009","unstructured":"Zhang EE, Liu AC, Hirota T, Miraglia LJ, Welch G, Pongsawakul PY, Liu X, Atwood A, Huss JW, Janes J, Su A, Hogenesch JB, Kay SA: A Genome-wide RNAi screen for modifiers of the circadian clock in human cells. [J] Cell. 2009, 139 (1): 199-210. 10.1016\/j.cell.2009.08.031.","journal-title":"[J] Cell"},{"issue":"2","key":"911_CR21","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1053\/gast.2000.9305","volume":"119","author":"LA Scheving","year":"2000","unstructured":"Scheving LA: Biological clocks and the digestive system. [J] Gastroenterology. 2000, 119 (2): 536-549. 10.1053\/gast.2000.9305.","journal-title":"[J] Gastroenterology"},{"issue":"11","key":"911_CR22","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1158\/0008-5472.CAN-08-4747","volume":"69","author":"PF Innominato","year":"2009","unstructured":"Innominato PF, Focan C, Gorlia T, Moreau T, Garufi C, Waterhouse J, Giacchetti S, Coudert B, Lacobelli S, Genet D, Tampellini M, Chollet P, Lentz MA, Mormont MC, Levi F, Bjarnason GA: Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. [J] Cancer Res. 2009, 69 (11): 4700-4707. 10.1158\/0008-5472.CAN-08-4747.","journal-title":"[J] Cancer Res"},{"issue":"4","key":"911_CR23","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1177\/1534735409352028","volume":"8","author":"I Keith","year":"2009","unstructured":"Keith I, Penny B, Susan R, Jamie S, April Y, Michael D, Deva N, Peter T, Amanda K, Charlotte G: Making circadian cancer therapy Practical. [J] Integr Cancer Ther. 2009, 8 (4): 371-386. 10.1177\/1534735409352028.","journal-title":"[J] Integr Cancer Ther"},{"issue":"1","key":"911_CR24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1200\/JCO.2000.18.1.136","volume":"18","author":"S Giachetti","year":"2002","unstructured":"Giachetti S, Perpoint B, Zidani R, Bail L, Faggiuolo R, Focan C, Chollet P, Llory JF, Letourneau Y, Coudert B, Bertheaut-Cvitkovic F, Larregain-Fournier D, Rol AL, Walter S, Adam R, Misset JL, Levi F: Phase III multicenter randomized trail of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. [J] J Clin Oncol. 2002, 18 (1): 136-147.","journal-title":"[J] J Clin Oncol"},{"issue":"1","key":"911_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1081\/CBI-120002602","volume":"19","author":"G Sylvie","year":"2002","unstructured":"Sylvie G: Chronotherapy of colorectal cancer. [J] Chronobiology International. 2002, 19 (1): 207-219. 10.1081\/CBI-120002602.","journal-title":"[J] Chronobiology International"},{"issue":"2","key":"911_CR26","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10549-008-0133-z","volume":"117","author":"XM Yang","year":"2009","unstructured":"Yang XM, Wood PA, Oh EY, Du-Qution J, Ansell CM, Hrushesky WJM: Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. [J] Breast Cancer Res Treat. 2009, 117 (2): 423-431. 10.1007\/s10549-008-0133-z.","journal-title":"[J] Breast Cancer Res Treat"},{"issue":"12","key":"911_CR27","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/mc.20446","volume":"47","author":"YM Lin","year":"2008","unstructured":"Lin YM, Chang JH, Yeh KT, Yang MY, Liu TC, Lin SF, Su WW, Chang JG: Disturbance of circadian gene expression in hepatocellular carcinoma. [J] Molecular Carcinogenesis. 2008, 47 (12): 925-933. 10.1002\/mc.20446.","journal-title":"[J] Molecular Carcinogenesis"},{"issue":"4","key":"911_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10552-005-9003-8","volume":"17","author":"CC Lee","year":"2006","unstructured":"Lee CC: Tumor suppression by the mammalian Period genes. [J] Cancer Causes Control. 2006, 17 (4): 525-530. 10.1007\/s10552-005-9003-8.","journal-title":"[J] Cancer Causes Control"},{"issue":"5506","key":"911_CR29","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1126\/science.1057499","volume":"291","author":"KL Toh","year":"2001","unstructured":"Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, Ptacek LJ, Fu YH: An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. [J] Science. 2001, 291 (5506): 1040-1043.","journal-title":"[J] Science"},{"issue":"6901","key":"911_CR30","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nature00965","volume":"418","author":"SM Reppert","year":"2002","unstructured":"Reppert SM, Weaver DR: Coordination of circadian timing in mammals. [J] Nature. 2002, 418 (6901): 935-941. 10.1038\/nature00965.","journal-title":"[J] Nature"},{"issue":"2","key":"911_CR31","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0896-6273(01)00302-6","volume":"3","author":"K Bae","year":"2001","unstructured":"Bae K, Jin X, Maywood ES, Hastings MH, Reppert SM, Weaver DR: Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. [J] Neuron. 2001, 3 (2): 525-536.","journal-title":"[J] Neuron"},{"issue":"5","key":"911_CR32","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0092-8674(01)00380-4","volume":"105","author":"B Zheng","year":"2001","unstructured":"Zheng B, Albrecht U, Kaasik K, Sage M, Lu W, Vaishnav S, Li Q, Sun ZS, Eichele G, Bradley A, Lee CC: Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. [J] Cell. 2001, 105 (5): 683-694. 10.1016\/S0092-8674(01)00380-4.","journal-title":"[J] Cell"},{"issue":"6740","key":"911_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/22118","volume":"400","author":"Larkin Zheng Binhai","year":"1999","unstructured":"Zheng Binhai Larkin, David W, Albrecht Urs, Sun Zhong Sheng, Sage Marijke, Eichele Gregor, Lee Cheng Chi, Bradley Allan: The mPer2 gene encodes a functional component of the mammalian circadian clock. [J] Nature. 1999, 400 (6740): 169-173. 10.1038\/22118.","journal-title":"[J] Nature"},{"issue":"1","key":"911_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/path.1756","volume":"206","author":"KT Yeh","year":"2005","unstructured":"Yeh KT, Yang MY, Liu TC, Chen JC, Chan WL, Lin SF, Chang JG: Abnormal expression of period 1 (PER1) in endometrial carcinoma. [J] J Pathol. 2005, 206 (1): 111-120. 10.1002\/path.1756.","journal-title":"[J] J Pathol"},{"issue":"19","key":"911_CR35","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.1111\/j.1742-4658.2009.07229.x","volume":"276","author":"N Remco","year":"2009","unstructured":"Remco N, Linda C, Reuven A: The miRNA-192\u2044194 cluster regulates the Period gene family and the circadian clock. [J] FEBS Journal. 2009, 276 (19): 5447-5455. 10.1111\/j.1742-4658.2009.07229.x.","journal-title":"[J] FEBS Journal"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-9-166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T17:56:19Z","timestamp":1630518979000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/1477-7819-9-166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["911"],"URL":"https:\/\/doi.org\/10.1186\/1477-7819-9-166","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"8 September 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"166"}}